Viral Hepatitis in Asia and the Pacific

Towards Elimination as a Public Health Threat

Häftad, Engelska, 2025

1 722 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt över 249 kr.

Beskrivning

Viral Hepatitis in Asia and the Pacific: Towards Elimination as a Public Health Threat documents the narratives, innovations, and scope of work in the Asia-Pacific region in starting, consolidating, and moving towards the elimination of viral hepatitis. The Asia-Pacific region is disproportionately affected by viral hepatitis, accounting for two-thirds of the global burden. Countries from low-, middle- and high-income economies have adopted different strategies to address combating and eliminating viral hepatitis. The successful experiences of the Asia-Pacific region are valuable for other regions, especially the middle- and low-income countries moving towards the achievement of the 2030 goal of elimination.

Strategies discussed include integrated approaches, negotiating universal access to diagnostics, and treatment options, including vaccines. Content further covers the critical barriers to achieve the 2030 targets for elimination of viral hepatitis and how to overcome them. This is the perfect reference for all hepatology researchers and elimination policy advocates who are dedicated to joining the fight for the 2030 goal of the elimination of viral hepatitis as a public health threat.

Focuses on the elimination of viral hepatitis as a global target through learning strategies and approaches in countries where hepatitis is most common
Provides the "how� behind the elimination of viral hepatitis, including integrated approaches and shifts in science and policy
?Presents updated information from multiple countries on the challenges and strategies that can be used toward the WHO's goal of eliminating viral hepatitis?

Produktinformation

Utgivningsdatum:2025-07-15
Mått:191 x 235 x 14 mm
Vikt:450 g
Format:Häftad
Språk:Engelska
Antal sidor:282
Förlag:Elsevier Science
ISBN:9780443236297

Utforska kategorier

Samhällsmedicin och preventiv medicin inom Medicin

Mer om författaren

Jing Sun is a professor at the College of Environmental Science and Engineering, Tongji University, China. She received her B.Sc. from Hohai University, China, and Ph.D. from the University of Queensland, Australia. Her research interests include understanding and controlling in-sewer processes for odor and corrosion mitigation, innovative biological treatment technologies for energy and resource recovery from wastewater and sludge, mathematical modeling of biological wastewater treatment processes, and emerging containments in wastewater, such as microplastics. She has published more than 70 peer-reviewed journal articles with 56 in the JCR Q1 journal and secured over 10 competitive research grants from the National Natural Science Foundation of China etc. She was awarded the Young Australia China Alumni of the Year Award in 2021. She served as a management committee member of the IWA Specialist Group on Modelling and Integrated Assessment Management and is also an editorial board member for 4 SCI journals.Dr Chan is the Regional Advisor for Hepatitis/HIV/STI in the World Health Organisation South-east Asia Regional Office (SEARO). She has served in countries and regions with WHO since 2005 in public health and communicable diseases prevention and control. Dr Chan graduated as a medical doctor from the University of Hong Kong, trained in women’s health, and in tropical medicine and epidemiology from the London School of Hygiene and Tropical Medicine. Ms Chee is the Executive Director of Third World Network, a non-profit international policy research and advocacy organization involved in sustainable development issues. She is an international lawyer whose areas of expertise include the environmental, social and economic impacts of globalization, especially in countries of the South. She holds degrees from the University of Malaya (Malaysia) and Cambridge University (UK).

Innehållsförteckning

Viral Hepatitis in Asia and the Pacific: Towards Elimination as a Public Health ThreatChapter 1 Epidemiology and response to viral hepatitis in Asia and the Pacific regionsPolin Chan, Tiara Mahatmi Nisa, Mohamed Amine Ghrabi, Kiyohiko Izumi, Amit Goel, Bharat Bhushan RewariChapter 2 Towards elimination of viral hepatitis B and C in AustraliaJisoo A. Kwon, David C. Boettiger, David NewbyChapter 3 Central pooled procurement and price negotiation: China’s strategies for affordable antiviral treatment of hepatitis B and CYihan Fu, Zhuoran Ma, Zhitao Wang, Shiyang Liu, Zhongdan Chen, Changsong Jiang, Jing SunChapter 4 Efforts towards elimination of viral hepatitis in IndiaAjeet Singh Bhadoria, Vineet Kumar Pathak, Pallav Bhattacharya, Pritam Roy, Gagandeep Grover, Pragya PandeyChapter 5 Hepatitis B Elimination in the Pacific Islands: Models of care delivery in KiribatiThomas Russell, David Hilmers, Caroline Lee, Alice LeeChapter 6 Government-led initiatives: a journey of enhancing hepatitis C treatment accessibility in MalaysiaMuhammad Radzi Abu Hassan, Huan Keat Chan, Han Yang Chung, Fazidah Binti YuswanChapter 7 Viral hepatitis elimination in MongoliaGereltuya Dorj, Baatarkhuu Oidov, Gantuya Dorj, Undram Lkhagvaa, Nick Walsh, Amarjargal Choijoo, Unenbat Gurbadam, Javkhlan Jargalsaikhan, Baasandorj ErdenetsetsegChapter 8 Hepatitis B immunizationXi Li, Sigrun RoeselChapter 9 South-South partnerships in developing affordable DAAs for low- and middle-income countriesTilak Ramanaidu, Jean-Michel Piedagnel, Han Yang Chung, Wing Loong CheongChapter 10 The ‘how’ of shifting a global paradigm: from dual to triple elimination of HIV, syphilis and viral hepatitis B Polin Chan, Hui Zheng, Ailing Wang, Fuzhen Wang, Jinlin Hou, Zhihua Liu, Jidong Jia, Lai Wei, Yu Wang, Timothy Hallett, Shevanthi Nayagam, Xiaoyan Wang, Qian Wang, Fuqiang Cui, Daniel Low-Beer, Philippa Easterbrook, Zhuang Hui, Lawrence Everett Rodewald